APPRAISE 2.0: Live Trial of the APPRAISE Trauma Decision Support System

Launched by ANDREW TOMAS REISNER · Nov 2, 2023

Keywords

ClinConnect Summary

The APPRAISE 2.0 trial is studying a new software system designed to help doctors make quick decisions when treating patients with serious injuries in the emergency department. This pilot study aims to see how well the software works during real-time use, whether it distracts or confuses doctors while they are treating patients, and to gather initial data that will help plan a larger study in the future.

To be eligible to participate, patients must be 18 years or older and be in the "Acute" area of the emergency department, which is where patients with critical health concerns are treated. They should have a clear concern for an acute injury. However, patients who are prisoners, pregnant, or have any concerns about using the software will not be included in the study. Participants in this trial can expect to have their treatment guided by both the software and the medical team, helping to improve care for trauma patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult (≥18 yrs) Emergency Department (ED) patient
• • Triaged to the "Acute" area of the ED. (The "Acute" area is the designated area for ED patients with potential or established critical illness. Triage to Acute is a routine ED operation that is performed based on departmental guidelines and the professional judgement of an experienced triage nurse).
• • Clinical concern for acute injury (based on either an explicitly chief complaint of acute injury, or clinical team with documented concern for acute injury as a relevant part of patient presentation).
• Exclusion Criteria:
• • Prisoners
• • Patients known to be pregnant, based on patient report, physical exam, or bedside ultrasound
• • Patients wearing an "EFIC Opt-Out" bracelet
• • Any concern about the suitability of the software system for a specific patient by any clinician involved in the patient's ED care, or by the patient themselves (or by any LAR \[lawfully authorized representative\] of the patient).